Arkolith/Insider Trading/GALT/Form 4

Lewis Joel

President and CEO, DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$55K
Net Open-Market Flow
-$55K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Sell(S)8K$7.06$55K833K
Dec 17, 2025Option exercise(M)8K$2.86$22K840K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)8K—$032K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-25-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML